Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · IEX Real-Time Price · USD
17.82
+0.16 (0.91%)
At close: Apr 25, 2024, 4:00 PM
18.00
+0.18 (1.01%)
After-hours: Apr 25, 2024, 6:36 PM EDT

Avadel Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2000
Net Income
-160.28-137.46-77.337.03-33.23-95.368.27-41.2841.8-85.47
Upgrade
Depreciation & Amortization
1.771.490.821.692.497.434.8814.4913.1314.14
Upgrade
Share-Based Compensation
15.817.018.8730.527.858.0714.687.742.69
Upgrade
Other Operating Activities
14.1958.65-9.67-60.45-8.1-2.69-64.5631.0121.6258.02
Upgrade
Operating Cash Flow
-128.51-70.3-77.31-48.73-38.33-82.7216.6618.984.29-10.62
Upgrade
Operating Cash Flow Growth
-------11.85%-77.58%--
Upgrade
Capital Expenditures
0-0.72-0.03-0.10.13-0.18-0.59-1.2-1.6311.51
Upgrade
Acquisitions
0016.525.50000.6300
Upgrade
Change in Investments
-50.0980.4140.46-95.1238.6-16.838-36.06-30.1-54.6
Upgrade
Other Investing Activities
------20-53.11---
Upgrade
Investing Cash Flow
-50.0979.756.93-69.7238.72-36.98-15.7-36.63-31.73-43.08
Upgrade
Share Issuance / Repurchase
148.36280.26179.680.12-27.06-21.960.446.99132.26
Upgrade
Debt Issued / Paid
-13.02-13.46000137.5600-4.91-34.35
Upgrade
Other Financing Activities
-----0.152.16-1.36-8.39-25.83-1.92
Upgrade
Financing Cash Flow
135.3414.540.26179.68-0.03112.66-23.32-7.95-23.7596
Upgrade
Exchange Rate Effect
0.46-0.66-0.90.720.08-0.2-0.3-0.17-3.51-9.17
Upgrade
Net Cash Flow
-42.8123.27-21.0161.950.45-7.24-22.65-25.8525.333.12
Upgrade
Free Cash Flow
-128.51-71.02-77.34-48.83-38.2-82.8916.0717.782.660.9
Upgrade
Free Cash Flow Growth
-------9.20%-78.59%9115.61%-
Upgrade
Free Cash Flow Margin
-459.58%---218.64%-64.51%-80.27%9.28%11.78%47.78%5.99%
Upgrade
Free Cash Flow Per Share
-1.60-1.18-1.32-0.92-1.02-2.220.400.432.040.03
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).